Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 18/20 | 0.58 |
| ▸ | HTR2C | P28335 | 18/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3948352 | 0.92 | HTR2A (0.67) | HTR2AHTR2CTSHRMAPTL3MBTL1 | |
| SCHEMBL3949986 | 0.92 | HTR2A (0.67) | HTR2AHTR2CTSHRMAPTL3MBTL1 | |
| SCHEMBL4042229 | 0.91 | HTR2A (0.66) | HTR2AHTR2CTSHRMAPTL3MBTL1 | |
| SCHEMBL3945404 | 0.90 | HTR2A (0.58) | HTR2AHTR2CTSHRHTTMAPT | |
| SCHEMBL3950888 | 0.89 | HTR2A (0.64) | HTR2AHTR2C | |
| SCHEMBL3947397 | 0.88 | HTR2A (0.63) | HTR2AHTR2CTSHRHTT | |
| SCHEMBL3948224 | 0.87 | HTR2A (0.64) | HTR2AHTR2C | |
| SCHEMBL3945494 | 0.83 | MAPT (0.61) | HTR2AHTR2CTSHRMAPTL3MBTL1 | |
| SCHEMBL4206004 | 0.82 | DRD4 (0.58) | HTR2AHTR2CTSHRMAPTL3MBTL1 | |
| SCHEMBL3953618 | 0.82 | HTR2A (0.68) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2051978-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| WO-2007136875-A2 | ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | claimed |